These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33190442)

  • 21. [Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
    Chen H; Liu KY; Xu LP; Liu DH; Chen YH; Zhao XS; Yu L; Han W; Zhang XH; Wang Y; Chen Y; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):77-81. PubMed ID: 19563015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation.
    Wang Y; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Wei F; Han W; Wang F; Wang J; Huang X; Mo X
    Virol J; 2024 May; 21(1):110. PubMed ID: 38745209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II-IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group.
    Kimura SI; Tamaki M; Okinaka K; Seo S; Uchida N; Igarashi A; Ozawa Y; Ikegame K; Eto T; Tanaka M; Shiratori S; Nakamae H; Sawa M; Kawakita T; Onizuka M; Fukuda T; Atsuta Y; Kanda Y; Nakasone H
    Ann Hematol; 2021 Dec; 100(12):3029-3038. PubMed ID: 34490500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of Plasmacytoid Dendritic Cell Dose in Grafts on CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation].
    Yao D; Tian YY; Lu J; Xiao PF; Ling J; Zheng DF; Gao J; Fan LY; Zheng JJ; Li J; Hu SY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1184-1191. PubMed ID: 37551496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of bronchoalveolar lavage fluid in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation].
    Li S; Wan LP; Xie GG; Bao AH; Sun Y; Shu W; Jiang JL; Yang J; Song XM; Wang C
    Zhonghua Xue Ye Xue Za Zhi; 2019 Oct; 40(10):822-826. PubMed ID: 31775480
    [No Abstract]   [Full Text] [Related]  

  • 26. Surveillance of CMV infection in allo-HSCT recipients and guidance on preemptive therapy by RQ-PCR.
    Li Y; Gao L; Wang LL; Ding Y; Xu YY; Li HH; Jing Y; Bo J; Huang WR; Wang QS; Gao CJ; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):161-8. PubMed ID: 23484712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia.
    Inagaki J; Noguchi M; Kurauchi K; Tanioka S; Fukano R; Okamura J
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):300-306. PubMed ID: 26371373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation.
    Ke P; Bao X; Zhou J; Li X; Zhuang J; He X; Wu D; Zhang X; Ma X
    Hematology; 2020 Dec; 25(1):43-47. PubMed ID: 31906810
    [No Abstract]   [Full Text] [Related]  

  • 29. Prior cytomegalovirus reactivation may lead to worse bacterial bloodstream infection outcomes in HSCT patients.
    Li S; Xiao Y; Jia M
    Transpl Immunol; 2024 Jun; 84():102038. PubMed ID: 38518827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
    Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
    Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation.
    Iglesias L; Perera MM; Torres-Miñana L; Pena-López MJ
    Bone Marrow Transplant; 2017 Jun; 52(6):895-897. PubMed ID: 28218754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytomegalovirus infection monitoring in patients with long-term survival after allogeneic hematopoietic stem cell transplantation].
    Chen L; Luo Y; Hu Y; Tan Y; Zhao Y; Fan J; Huang H
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3145-9. PubMed ID: 25573309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneously-resolving episodes of cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: Virological features and clinical outcomes.
    Talaya A; Giménez E; Piñana JL; Albert E; Hernández-Boluda JC; Pérez A; Torres I; Solano C; Navarro D
    J Med Virol; 2019 Jun; 91(6):1128-1135. PubMed ID: 30735250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors of cytomegalovirus infection and antiviral efficacy in recipients of hematopoietic stem cell transplantation].
    Ding H; Ren H; Guo N; Huang X; Xu L; Zhang Y; Lu D
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 35(6):596-9. PubMed ID: 14710251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for T lymphoblastic leukemia/lymphoma].
    Luo L; Jiao Y; Yang P; Li Y; Huang WY; Ke XY; Zou DH; Jing HM
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):388-394. PubMed ID: 37550188
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.
    Liu YC; Lu PL; Hsiao HH; Chang CS; Liu TC; Yang WC; Lin SF
    Ann Hematol; 2012 Apr; 91(4):587-95. PubMed ID: 21997849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
    Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
    Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinical evaluation of preemptive treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
    Zhang P; Wang C; Jiang JL; Jiang Y; Yan SK; Yang J
    Zhonghua Nei Ke Za Zhi; 2009 Jul; 48(7):539-41. PubMed ID: 19957791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surveillance of cytomegalovirus for antiviral efficacy and risk factors in allogeneic hematopoietic stem cell transplantation].
    Jia JS; Liu DP; Huang XJ; Wu T; Liu DH; Zhang YC; Su H; Wang JB; Zhou JR; Liu Q; Ying MY; Sun RJ; Duan X; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):749-54. PubMed ID: 16928314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.